While molecular testing remains the gold standard for COVID-19 diagnosis, serological testing enables the evaluation of the immune response to SARS-CoV-2 infection and vaccination. This webinar focuses on the immune response, current testing trends and challenges for COVID-19 detection. Dr. Henry also discusses the emerging rapid variants and breakthrough infections and how we can be prepared for 2022. Dr. Sabalza addresses key scientific publications on humoral & cellular immune responses in COVID-19.
Brandon Henry, MD
Cincinnati Children’s Hospital Medical Center
Texas Biomedical Research Institute
Maite Sabalza, PhD
Scientific Affairs Manager, EUROIMMUN US
To view this webinar, please complete the following form.
2024 EUROIMMUN US
